scispace - formally typeset
P

Peddy Vishweshwar

Researcher at Dr. Reddy's Laboratories

Publications -  47
Citations -  4803

Peddy Vishweshwar is an academic researcher from Dr. Reddy's Laboratories. The author has contributed to research in topics: Hydrogen bond & Crystal engineering. The author has an hindex of 23, co-authored 47 publications receiving 4407 citations. Previous affiliations of Peddy Vishweshwar include University of Hyderabad & University of South Florida.

Papers
More filters
Journal ArticleDOI

Pharmaceutical Co-Crystals

TL;DR: This review addresses how crystal engineering has been applied to active pharmaceutical ingredients, API's, with emphasis upon how pharmaceutical co-crystals, a long known but little explored alternative to the four traditionally known forms of API, can be generated in a rational fashion.
Journal ArticleDOI

Polymorphs, Salts, and Cocrystals: What’s in a Name?

TL;DR: A discussion of the FDA guidance on regulatory classification of pharmaceutical cocrystals of active pharmaceutical ingredients (APIs) was held in Manesar near Delhi, India, from February 2-4, 2012 as mentioned in this paper.
Journal ArticleDOI

Hierarchy of Supramolecular Synthons: Persistent Carboxylic Acid···Pyridine Hydrogen Bonds in Cocrystals That also Contain a Hydroxyl Moiety

TL;DR: In this paper, the authors evaluate the hierarchy of supramolecular heterosynthons that involve two of the most relevant functional groups in the context of active pharmaceutical ingredients, carboxylic acids and alcohols, in competitive environments.
Journal ArticleDOI

Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation from Solution

TL;DR: The reliability of solvent drop grinding (SDG), also referred to as liquid assisted grinding, wet cogrinding, or mechanochemistry, to facilitate cocrystal formation is addressed with a series of model cocrystals as mentioned in this paper.
Journal ArticleDOI

The Predictably Elusive Form II of Aspirin

TL;DR: The elusive form II of aspirin has been obtained during co-crystallization experiments with levetiracetam or acetamide, and it has been characterized by IR, DSC, HPLC, and single-crystal X-ray diffraction.